BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report) shares rose 3.9% on Thursday . The stock traded as high as $1.88 and last traded at $1.85. Approximately 50,428 shares traded hands during mid-day trading, a decline of 100% from the average daily volume of 62,169,492 shares. The stock had previously closed at $1.78.
BioRestorative Therapies Trading Down 5.6 %
The company has a market cap of $2.79 billion, a price-to-earnings ratio of -1.59 and a beta of 102.36. The firm has a 50-day moving average price of $1.94 and a 200 day moving average price of $1.73.
About BioRestorative Therapies
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Featured Stories
- Five stocks we like better than BioRestorative Therapies
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- Should You Invest in Penny Stocks?
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
